Beta Bionics (BBNX) Total Current Liabilities (2023 - 2026)
Beta Bionics (BBNX) posted Total Current Liabilities of $26.0 million for Q2 2026, up 12.19% sequentially from $23.2 million in Q1 2026, and up 33.5% YoY from $19.5 million in Q2 2025.
Beta Bionics (BBNX) Total Current Liabilities (2023 - 2026) Analysis & Trends
Beta Bionics has reported Total Current Liabilities for 4 years, with the latest figure at $26.0 million in Q2 2026.
- Quarterly Total Current Liabilities rose 33.5% year-over-year to $26.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $26.0 million (up 33.5% YoY) and the FY2025 annual result came in at $30.9 million, up 46.23% from the prior year.
- Total Current Liabilities climbed to $26.0 million in Q2 2026 per BBNX's latest filing, from $23.2 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $30.9 million in Q4 2025 and troughed at $10.6 million in Q4 2023.
- A 4-year average of $21.7 million and a median of $22.2 million in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2024 and 2026: Total Current Liabilities surged 99.42% in 2024, then surged 33.5% in 2026.
- Over 4 years, Total Current Liabilities stood at $10.6 million in 2023, then soared by 99.42% to $21.1 million in 2024, then surged by 46.23% to $30.9 million in 2025, then fell by 15.87% to $26.0 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $26.0 million, $23.2 million, and $30.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.90 Bn | 7.27 Bn | 17.81 Bn |
| 2 | Stryker | 126.12 Bn | 122.64 Bn | 4.50 Bn | 6.68 Bn |
| 3 | Medtronic | 118.45 Bn | 109.23 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 73.30 Bn | 72.77 Bn | 3.85 Bn | 6.43 Bn |
| 5 | Edwards Lifesciences | 51.60 Bn | 47.35 Bn | 1.35 Bn | 1.51 Bn |
| 6 | Dexcom | 34.52 Bn | 32.57 Bn | 830.00 Mn | 2.36 Bn |
| 7 | GE HealthCare Technologies | 33.71 Bn | 31.60 Bn | 2.18 Bn | 8.30 Bn |
| 8 | Koninklijke Philips | 26.14 Bn | 22.82 Bn | 4.55 Bn | 8.63 Bn |
| 9 | Steris | 23.13 Bn | 22.65 Bn | 684.20 Mn | 1.28 Bn |
| 10 | Beta Bionics | 845.47 Mn | 664.98 Mn | 18.90 Mn | 26.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.02 Mn |
| Mar 31, 2026 | 23.19 Mn |
| Dec 31, 2025 | 30.92 Mn |
| Sep 30, 2025 | 25.39 Mn |
| Jun 30, 2025 | 19.49 Mn |
| Mar 31, 2025 | 16.49 Mn |
| Dec 31, 2024 | 21.15 Mn |
| Dec 31, 2023 | 10.61 Mn |